Table 3. Multiple linear regression model of the onset latency of lower trapezius and serratus anterior, adjusted by the additive combination of the variables: body mass index, percentage of body fat, skinfolds, and fatigue in no-fatigue (n = 17) and fatigue (n = 17) groups.
| R2 | β | P | 95% CI | |||
|---|---|---|---|---|---|---|
| Lower Trapezius Onset Latency | Model 1 - Body Mass Index | 0.08 | −15.6 | 0.336 | −48.4 | 17.0 |
| Model 2 - Body Fat percentage | 0.10 | −0.1 | 0.968 | −6.8 | 6.5 | |
| Model 3 - Axillary Skinfold | 0.37 | 7.4 | 0.016* | 1.4 | 13.4 | |
| Model 4 - Fatigue | 0.75 | 79.2 | 0.000* | 55.4 | 103.0 | |
| Model 1 - Body Mass Index | 0.08 | 0.2 | 0.987 | −33.0 | 33.5 | |
| Model 2 - Body Fat percentage | 0.10 | 5.8 | 0.077 | −0.6 | 12.3 | |
| Model 3 - Pectoral Skinfold | 0.19 | −0.6 | 0.782 | −5.0 | 3.8 | |
| Model 4 - Fatigue | 0.70 | 89.4 | 0.000* | 63.4 | 115.4 | |
| Model 1 - Body Mass Index | 0.08 | −2.1 | 0.899 | −35.9 | 31.7 | |
| Model 2 - Body Fatpercentage | 0.10 | 4.2 | 0.196 | −2.3 | 10.7 | |
| Model 3 - Subscapular Skinfold | 0.23 | 1.7 | 0.499 | −3.4 | 6.9 | |
| Model 4 - Fatigue | 0.70 | 87.5 | 0.000* | 61.5 | 113.4 | |
| Serratus Anterior Onset Latency | Model 1 - Body Mass Index | 0.14 | 6.4 | 0.738 | −32.7 | 45.6 |
| Model 2 - Body Fat percentage | 0.15 | −0.5 | 0.885 | −8.5 | 7.4 | |
| Model 3 - Axillary Skinfold | 0.36 | 7.2 | 0.047* | 0.1 | 14.4 | |
| Model 4 - Fatigue | 0.78 | 104.2 | 0.000* | 75.7 | 132.7 | |
| Model 1 - Body Mass Index | 0.14 | 21.3 | 0.243 | −15.3 | 58.1 | |
| Model 2 - Body Fat percentage | 0.15 | 8.0 | 0.030* | 0.8 | 15.2 | |
| Model 3 - Pectoral Skinfold | 0.33 | −4.2 | 0.089 | −9.1 | 0.6 | |
| Model 4 - Fatigue | 0.77 | 106.5 | 0.000* | 77.9 | 135.2 | |
| Model 1 - Body Mass Index | 0.14 | 6.7 | 0.639 | −22.5 | 36.1 | |
| Model 2 - Body Fat percentage | 0.15 | −2.3 | 0.401 | −7.9 | 3.2 | |
| Model 3 - Subscapular Skinfold | 0.51 | 10.7 | 0.000* | 6.2 | 15.3 | |
| Model 4 - Fatigue | 0.86 | 95.4 | 0.000* | 72.9 | 117.8 | |
Notes.
significant difference (P < 0.05); 95% CI, 95% confidence interval.